Nutritional Supplement Ocoxin ® Combined with Gemcitabine-Based Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Nutritional Supplement Ocoxin ® Combined with Gemcitabine-Based Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Pathology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
,
Clinical Section, National Coordinating Centre for Clinical Trials, Havana, Cuba
,
Clinical Section, National Coordinating Centre for Clinical Trials, Havana, Cuba
,
Biostatistics Section, National Coordinating Centre for Clinical Trials, Havana, Cuba
1 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
2 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
3 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
4 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
5 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
6 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
7 Clinical Pathology Department, Ameijeiras Hospital, Havana, Cuba
8 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
9 Clinical Oncology Department, Ameijeiras Hospital, Havana, Cuba
10 Clinical Section, National Coordinating Centre for Clinical Trials, Havana, Cuba
11 Clinical Section, National Coordinating Centre for Clinical Trials, Havana, Cuba
12 Biostatistics Section, National Coordinating Centre for Clinical Trials, Havana, Cuba
Background : the quality of life (QoL) of patients with pancreatic ductal adenocarcinoma (PDAC), with its limited survival, can be affected by chemotherapy-induced toxicity. The main objective was to evaluate the effect of introducing ocoxin oral solution (OOS) in combination with standard therapy on quality of life. Methods : Thirty patients were enrolled in an exploratory, prospective, single-centre clinical trial in the oncology department of “Hermanos Ameijeiras” University Hospital in Havana, Cuba. Quality of life was measured using the EORTC QLQ-C30 questionnaire and toxicity was assessed using the NCI-CTC-AE classification version 5.0. Results : There was stability in the scores over time for overall QoL and the functional scale criteria, while in terms of symptoms, fatigue, pain and loss of appetite were reduced. No grade 3 - 4 adverse events (AEs) were recorded, and only 14.9% of toxicities were classified as grade 2, and these were considered to be unrelated to OOS. Biochemical and nutritional parameters were normalised at 12 months compared to the baseline values. Conclusions : This clinical study is the first report of the use of OOS in patients with advanced pancreatic cancer, and demonstrates that it is able to maintain optimal quality of life with reduced severity of toxicity during and after combination treatment with gemcitabine-based chemotherapy.
KeywordsEORTC QLQ-C30OcoxinChemotherapyPancreatic CancerQuality of Life
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA : A Cancer Journal for Clinicians , 71, 209-249. https://doi.org/10.3322/caac.21660
Lima Pérez, M., Galán Alvarez, Y., Soriano García, J., Iglesias Ventura, Y. and Medina Pérez, V. (2021) Incidencia y mortalidad en Cuba por cáncer del sistema digestivo, 2015-2017. Revista Cubana de Oncología , 19, e142. https://revoncologia.sld.cu/index.php/onc/article/view/142
Rawla, P., Sunkara, T. and Gaduputi, V. (2019) Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World Journal of Oncology , 10, 10-27. https://doi.org/10.14740/wjon1166
McGuigan, A., Kelly, P., Turkington, R.C., Jones, C., Coleman, H.G. and McCain, R.S. (2018) Pancreatic Cancer: A Review of Clinical Diagnosis, Epidemiology, Treatment and Outcomes. World Journal of Gastroenterology , 24, 4846-4861. https://doi.org/10.3748/wjg.v24.i43.4846
Blomstrand, H., Batra, A., Cheung, W.Y. and Elander, N.O. (2021) Real-World Evidence on First-and Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer. World Journal of Clinical Oncology , 12, 787-799. https://doi.org/10.5306/wjco.v12.i9.787
Hayes, J.D., Dinkova-Kostova, A.T. and Tew, K.D. (2020) Oxidative Stress in Cancer. Cancer Cell , 38, 167-197. https://doi.org/10.1016/j.ccell.2020.06.001
Zou, Z., Chang, H., Li, H. and Wang, S. (2017) Induction of Reactive Oxygen Species: An Emerging Approach for Cancer Therapy. Apoptosis : An International Journal on Programmed Cell Death , 22, 1321-1335. https://doi.org/10.1007/s10495-017-1424-9
Yasueda, A., Urushima, H. and Ito, T. (2016) Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review. Integrative Cancer Therapies , 15, 17-39. https://doi.org/10.1177/1534735415610427
Pandiella-Alonso, A., Díaz-Rodríguez, E. and Sanz, E. (2020) Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review. Nutrients , 12, Article 2661. https://doi.org/10.3390/nu12092661
Pérez-Peña, J., Díaz-Rodríguez, E., Sanz, E. and Pandiella, A. (2019) Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin. Nutrients , 11, Article 1068. https://doi.org/10.3390/nu11051068
García-Perdomo, H.A., Gómez-Ospina, J.C. and Reis, L.O. (2021) Immunonutrition Hope? Oral Nutritional Supplement on Cancer Treatment. International Journal of Clinical Practice , 75, e14625. https://doi.org/10.1111/ijcp.14625
Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Flechtner, H., Fleishman, S.B. and De Haes, J.C. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. Journal of the National Cancer Institute , 85, 365-376. https://doi.org/10.1093/jnci/85.5.365
Cocks, K., King, M.T., Velikova, G., De Castro, G., Martyn St-James, M., Fayers, P.M. and Brown, J.M. (2012) Evidence-Based Guidelines for Interpreting Change Scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer , 48, 1713-1721. https://doi.org/10.1016/j.ejca.2012.02.059
Kamisawa, T., Wood, L.D., Itoi, T. and Takaori, K. (2016) Pancreatic Cancer. The Lancet , 388, 73-85. https://doi.org/10.1016/j.ejca.2012.02.059
Tasic, I. and Lovic, D. (2018) Hypertension and Cardiometabolic Disease. Frontiers in Bioscience , 10, 166-174. https://doi.org/10.2741/s506
Chu, L.C., Goggins, M.G. and Fishman, E.K. (2017) Diagnosis and Detection of Pancreatic Cancer. Cancer Journal , 23, 333-342. https://doi.org/10.1097/PPO.0000000000000290
Gómez-España, M.A., Montes, A.F., Garcia-Carbonero, R., Mercadé, T.M., Maurel, J., Martín, A.M., Pazo-Cid, R., Vera, R., Carrato, A. and Feliu, J. (2021) SEOM Clinical Guidelines for Pancreatic and Biliary Tract Cancer (2020). Clinical & Translational Oncology , 23, 988-1000. https://doi.org/10.1007/s12094-021-02573-1
Ghosn, M., Ibrahim, T., Assi, T., El Rassy, E., Kourie, H.R. and Kattan, J. (2016) Dilemma of First Line Regimens in Metastatic Pancreatic Adenocarcinoma. World Journal of Gastroenterology , 22, 10124-10130. https://doi.org/10.3748/wjg.v22.i46.10124
Goess, R. and Friess, H. (2018) A Look at the Progress of Treating Pancreatic Cancer over the Past 20 Years. Expert Review of Anticancer Therapy , 18, 295-304. https://doi.org/10.1080/14737140.2018.1428093
Ansari, D., Tingstedt, B., Andersson, B., Holmquist, F., Sturesson, C., Williamsson, C., Sasor, A., Borg, D., Bauden, M. and Andersson, R. (2016) Pancreatic Cancer: Yesterday, Today and Tomorrow. Future Oncology , 12, 1929-1946. https://doi.org/10.2217/fon-2016-0010
Hu, J., Zhao, G., Wang, H.X., Tang, L., Xu, Y.C., Ma, Y. and Zhang, F.C. (2011) A Meta-Analysis of Gemcitabine Containing Chemotherapy for Locally Advanced and Metastatic Pancreatic Adenocarcinoma. Journal of Hematology & Oncology , 4, Article 11. https://doi.org/10.1186/1756-8722-4-11
Lima-Pérez, M., Soriano-García, J.L., González-Meisozo, M., Rodríguez-Barrios, R., Vals-Machado, Y., Domínguez-Álvarez, C., Morales-Morgado, D., Fleites-Calvo, V., Ramón-Concepción, I. and Batista-Albuerne, N. (2021) Nimotuzumab combinado con un esquema de quimioterapia GEMOX en pacientes con cáncer pancreático avanzado. VacciMonitor , 30, 133-144. https://vaccimonitor.finlay.edu.cu/index.php/vaccimonitor/article/view/278
Mękal, D., Sobocki, J., Badowska-Kozakiewicz, A., Sygit, K., Cipora, E., Bandurska, E., Czerw, A. and Deptała, A. (2023) Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer. Cancers , 15, Article 3816. https://doi.org/10.3390/cancers15153816
Bundred, J., Kamarajah, S.K. and Roberts, K.J. (2019) Body Composition Assessment and Sarcopenia in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. HPB , 21, 1603-1612. https://doi.org/10.1016/j.hpb.2019.05.018
Liang, C., Shi, S., Meng, Q., Liang, D., Ji, S., Zhang, B., Qin, Y., Xu, J., Ni, Q. and Yu, X. (2018) Do Anti-Stroma Therapies Improve Extrinsic Resistance to Increase the Efficacy of Gemcitabine in Pancreatic Cancer? Cellular and Molecular Life Sciences , 75, 1001-1012. https://doi.org/10.1007/s00018-017-2678-7
Hernandez-Unzueta, I., Benedicto, A., Romayor, I., Herrero, A., Sanz, E., Arteta, B., Olaso, E. and Márquez, J. (2019) Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas , 48, 555-567. https://doi.org/10.1097/MPA.0000000000001277
Wong, H.C.Y., Lam, K.Y., Chong, C.C.N., Chan, A.W.H. and Chan, S.L. (2019) Impact of Weight Loss During Chemotherapy in Chinese Patients with Unresectable Pancreatic Cancer. Nutrition and Cancer , 71, 954-970. https://doi.org/10.1080/01635581.2019.1595047
Kordes, M., Larsson, L., Engstrand, L. and Löhr, J.M. (2021) Pancreatic Cancer Cachexia: Three Dimensions of a Complex Syndrome. British Journal of Cancer , 124, 1623-1636. https://doi.org/10.1038/s41416-021-01301-4
Padoan A., Plebani M. and Basso D. (2019) Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity. International Journal of Molecular Sciences , 20, Article 676. https://doi.org/10.3390/ijms20030676
Meyer-Knees, J.W., Falkenthal, J., Geisel, D., Neumann, C.C.M., Hilfenhaus, G., Stephan, L.U., Schöning, W., Malinka, T., Pratschke, J., Stintzing, S. and Pelzer, U. (2024) Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 Investigation. Cancers , 16, Article 1194. https://doi.org/10.3390/cancers16061194
Márquez, J., Mena, J., Hernandez-Unzueta, I., Benedicto, A., Sanz, E., Arteta, B. and Olaso, E. (2016) Ocoxin® Oral Solution Slows Down Tumor Growth in an Experimental Model of Colorectal Cancer Metastasis to the Liver in Balb/c Mice. Oncology Reports , 35, 1265-1272. https://doi.org/10.3892/or.2015.4486
Kim, H.J., Lee, S.Y., Kim, D.S., Kang, E.J., Kim, J.S., Choi, Y.J., Oh, S.C., Seo, J.H. and Kim, J.S. (2020) Inflammatory Markers as Prognostic Indicators in Pancreatic Cancer Patients Who Underwent Gemcitabine-Based Palliative Chemotherapy. The Korean Journal of Internal Medicine , 35, 171-184. https://doi.org/10.3904/kjim.2018.076
Soriano-Lorenzo, J., Lima-Pérez, M., Soriano-García, J., González-Meisozo, M., Domínguez-Álvarez, C., Quesada-Peña, S., Morales-Morgado, D., Fleites-Calvo, V., Ramón-Concepción, I., Batista-Albuerne, N. and Rodríguez-Barrios, R. (2021) Índice neutrófilo/linfocito como factor pronóstico en pacientes con adenocarcinoma pancreático avanzado tratados con quimioinmunoterpia. Revista Cubana de Oncología , 19, e131. https://revoncologia.sld.cu/index.php/onc/article/view/131
Benedicto, A., Sanz, E. and Márquez, J. (2021) Ocoxin as a Complement to First Line Treatments in Cancer. International Journal of Medical Sciences , 18, 835-845. https://doi.org/10.7150/ijms.50122
Principe, D.R., Narbutis, M., Kumar, S., Park, A., Viswakarma, N., Dorman, M.J., Kamath, S.D., Grippo, P.J., Fishel, M.L., Hwang, R.F., Thummuri, D., Underwood, P.W., Munshi, H.G., Trevino, J.G. and Rana, A. (2020) Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy. Cancer Research , 80, 3101-3115. https://doi.org/10.1158/0008-5472.CAN-19-2959
Stojanovska, V., Prakash, M., McQuade, R., Fraser, S., Apostolopoulos, V., Sakkal, S. and Nurgali, K. (2019) Oxaliplatin Treatment Alters Systemic Immune Responses. BioMed Research International , 2019, Article 4650695. https://doi.org/10.1155/2019/4650695
Mazorra, Z., Lavastida, A., Concha-Benavente, F., Valdés, A., Srivastava, R.M., García-Bates, T.M., Hechavarría, E., González, Z., González, A., Lugiollo, M., Cuevas, I., Frómeta, C., Mestre, B.F., Barroso, M.C., Crombet, T. and Ferris, R.L. (2017) Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells In Head and Neck Cancer Patients. Frontiers in Pharmacology , 8, Article 382. https://doi.org/10.3389/fphar.2017.00382
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M.G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al . (2005) Gemcitabine in Combination with Oxaliplatin compared with Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial. Journal of Clinical Oncology , 23, 3509-3516. https://doi.org/10.1200/JCO.2005.06.023
Rivas, I.C., Silva, J., Alfonso, G., Candanedo, H., Cuervo, Y.R., Mestre, B.F., Cabello, J.R., Lence, J.J., Lugoyo, M. and Sanz, E. (2018) Oncoxin-Viusid with Radiotherapy and Chemotherapy in Patients with Head and Neck Cancer: Results from a Phase II, Randomised, Double-Blind Study. Journal of Cancer Science & Therapy , 10, 317-327. https://doi.org/10.4172/1948-5956.1000562
Kang, L., Tian, Y., Xu, S. and Chen, H. (2021) Oxaliplatin-Induced Peripheral Neuropathy: Clinical Features, Mechanisms, Prevention and Treatment. Journal of Neurology , 268, 3269-3282. https://doi.org/10.1007/s00415-020-09942-w
Gao, A., Zhang, L. and Zhong, D. (2023) Chemotherapy-Induced Thrombocytopenia: Literature Review. Discover Oncology , 14, Article No. 10. https://doi.org/10.1007/s12672-023-00616-3
Yang, Y., Zhao, B., Gao, X., Sun, J., Ye, J., Li, J. and Cao, P. (2021) Targeting Strategies for Oxaliplatin-Induced Peripheral Neuropathy: Clinical Syndrome, Molecular Basis, and Drug Development. Journal of Experimental & Clinical Cancer Research , 40, Article No. 331. https://doi.org/10.1186/s13046-021-02141-z
Klein, I., Isensee, J., Wiesen, M.H.J., Imhof, T., Wassermann, M.K., Müller, C., Hucho, T., Koch, M. and Lehmann, H.C. (2023) Glycyrrhizic Acid Prevents Paclitaxel-Induced Neuropathy via Inhibition of OATP-Mediated Neuronal Uptake. Cells , 12, Article 1249. https://doi.org/10.3390/cells12091249
Lorente, R., Durán, D., Viamontes, J., Anta, J., Reyes, R. and Navares, E. (2020) Efficacy of Oncoxin-Viusid on the Reduction of Adverse Reactions to Chemotherapy and Radiotherapy in Patients Diagnosed with Cervical Cancer and Endometrial Adenocarcinoma. Journal of Cancer Therapy , 11, 276-295. https://doi.org/10.4236/jct.2020.115023
Buck, I., Morceau, F., Grigorakaki, C., Dicato, M. and Diederich, M. (2009) Linking Anemia to Inflammation and Cancer: The Crucial Role of TNFa. Biochemical Phar macology , 77, 1572-1579. https://doi.org/10.1016/j.bcp.2008.12.018
Chu, T., Hu, S., Qi, J., Li, X., Zhang, X., Tang, Y., Yang, M., Xu, Y., Ruan, C.G., Han, Y. and Wu, D.P. (2022) Bifunctional Effect of the Inflammatory Cytokine Tumor Necrosis Factor α on Megakaryopoiesis and Platelet Production. Journal of Thrombosis and Haemostasis , 20, 2998-3010. https://doi.org/10.1111/jth.15891
Pérez-Burillo, S., Navajas-Porras, B., López-Maldonado, A., Hinojosa-Nogueira, D., Pastoriza, S. and Rufián-Henares, J.Á. (2021) Green Tea and Its Relation to Human Gut Microbiome. Molecules , 26, Article 3907. https://doi.org/10.3390/molecules26133907
Zhang, Y., Sheng, Z., Xiao, J., Li, Y., Huang, J., Jia, J., Zeng, X. and Li, L. (2023) Advances in the Roles of Glycyrrhizic Acid in Cancer Therapy. Frontiers in Pharmacology , 14, Article 1265172. https://doi.org/10.3389/fphar.2023.1265172
Bak, Y.K., Lampe, J.W. and Sung, M.K. (2014) Effects of Dietary Supplementation of Glucosamine Sulfate on Intestinal Inflammation in a Mouse Model of Experimental Colitis. Journal of Gastroenterology and Hepatology , 29, 957-963. https://doi.org/10.1111/jgh.12485
Wan, Y. and Zhang, B. (2022) The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases. Biomolecules , 12, Article 900. https://doi.org/10.3390/biom12070900
Shumsky, A., Bilan, E., Sanz, E. and Petrovskiy, F. (2019) Oncoxin Nutritional Supplement in the Management of Chemotherapy-and/or Radiotherapy-Associated Oral Mucositis. Molecular and Clinical Oncology , 10, 463-468. https://doi.org/10.3892/mco.2019.1809
Chung, V., Sun, V., Ruel, N., Smith, T.J. and Ferrell, B.R. (2022) Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients. Journal of Palliative Medicine , 25, 720-727. https://doi.org/10.1089/jpm.2021.0187
Miguel, K., Ávila, D., Pérez, L., Rabasa, G., Lambert, A., Noa, R., et al . (2022) The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy. Journal of Cancer Therapy , 13, 561-584. https://doi.org/10.4236/jct.2022.139050
Fundora-Ramos, M.I., Maden, L.B., Casanova, F.O., Cruz, F.H., Reyes, C.S., Gato, A.H., Lyncon, I.B., González, E.V., Morales, K.P., Lence, J.J. and Sanz, E. (2021) Oncoxin-Viusid® May Improve Quality of Life and Survival in Patients with Hormone-Refractory Prostate Cancer Undergoing Onco-Specific Treatments. Molecular and Clinical Oncology , 14, Article 5. https://doi.org/10.3892/mco.2020.2167
Hameed, M., Hameed, H. and Erdek, M. (2011) Pain Management in Pancreatic Cancer. Cancers , 3, 43-60. https://doi.org/10.3390/cancers3010043
Mayr, M. and Schmid, R.M. (2010) Pancreatic Cancer and Depression: Myth and Truth. BMC Cancer , 10, Article 569. https://doi.org/10.1186/1471-2407-10-569
Lee J. (2022) Prediction Model of the Quality of Life for Patients with Pancreatic Cancer. Healthcare , 10, Article 1973. https://doi.org/10.3390/healthcare10101973
Poulia, K.A., Antoniadou, D., Sarantis, P. and Karamouzis, M.V. (2022) Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study. Nutrients , 14, Article 442. https://doi.org/10.3390/nu14030442
BBC News Mundo (2024) Crisis en Cuba. https://www.bbc.com/mundo/articles/c0xy21vlexeo
Alexander, A., Fung, S., Eichler, M., Lehwald-Tywuschik, N., Uthayakumar, V., Safi, S.A., Vay, C., Ashmawy, H., Kalmuk, S., Rehders, A., Vaghiri, S. and Knoefel, W.T. (2022) Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health , 19, Article 3731. https://doi.org/10.3390/ijerph19063731
Castillo-Martínez, L., Castro-Eguiluz, D., Copca-Mendoza, E.T., Pérez-Camargo, D.A., Reyes-Torres, C.A., Ávila, E.A., López-Córdova, G., Fuentes-Hernández, M.R, Cetina-Pérez, L. and Milke-García, M.D.P. (2018) Nutritional Assessment Tools for the Identification of Malnutrition and Nutritional Risk Associated with Cancer Treatment. Revista de Investigación Clínica , 70, 121-125. https://doi.org/10.24875/RIC.18002524
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., et al . (2021) ESPEN Practical Guideline: Clinical Nutrition in Cancer. Clinical Nutrition , 40, 2898-2913. https://doi.org/10.1016/j.clnu.2021.02.005